Long COVID/PASC

Advocacy

AAPM&R is Calling for a Comprehensive National Plan to Address the Needs of Millions Suffering from Long COVID

According to two recent publications from the Journal of the American Medical Association, ten to thirty percent of individuals who had COVID-19 reported at least one persistent symptom up to six months after the virus left their bodies. That means 3 to 10 million Americans are experiencing symptoms of Long COVID or Post-Acute Sequelae of SARS-CoV-2 infection (PASC), which are varied and ongoing, including neurological challenges, cognitive problems such as brain fog, shortness of breath, fatigue, pain, and mobility issues.

AAPM&R called on President Joe Biden and Congress to gear up for the next coronavirus crisis by preparing and implementing a comprehensive national plan focused on meeting the needs of millions of individuals suffering from the long-term symptoms of COVID-19, and help them regain quality of life and return to being active members of their communities. The plan must include a commitment to three major components:

  • Resources to build necessary infrastructure to meet this crisis
  • Equitable access to care for patients
  • Research to advance medical understanding of Long COVID

PM&R physicians are uniquely qualified to help guide the multidisciplinary effort needed to develop a plan for this crisis. As a specialty, physiatrists are investigators, team leaders and problem solvers. PM&R physicians see the whole patient AND the whole picture of the rehabilitation ecosystem. Physiatrists are exactly what this crisis needs. Learn more about our Multidisciplinary PASC Collaborative, launched in March 2021, which is working on quality improvement initiatives.

AAPM&R Advocacy, Healthcare Collaborations and Partnerships, and Customized Resources to Support PM&R During This Crisis

AAPM&R is working to ensure PM&R is part of the national conversation about healthcare amidst COVID-19 and advocating for the federal support, legislation, regulation relief and resources that physiatrists need now. One way we are doing this is through our partnerships and collaborations with other specialty societies. The Academy continuously works to represent PM&R through these collaborations, and it is through these partnerships that we are able to discuss and share a variety of resources with you that you critically need.

Stay Up-to-Date

CMS to Implement Prior Authorization for Lower Limb Prosthetics

Aug 26, 2020

Prior to the COVID-19 public health emergency (PHE), the Centers for Medicare and Medicaid Services (CMS) stated that six lower limb prosthetic Healthcare Common Procedure Coding System (HCPCS) codes (L-5856, L-5857, L-5858, L-5973, L-5980, and L-5987) would be subject to prior authorization as a Medicare condition of payment in four states (Texas, Pennsylvania, Michigan, and California) beginning May 11, 2020. These states would serve as a pilot program testing the new prior authorization requirements, which would be implemented nationwide beginning October 8. In light of the pandemic, CMS paused this new program for lower limb prosthetics in March.

On July 1, CMS announced that it will resume this program and require prior authorization for the six codes with dates of service on or after September 1, 2020 in the same four states, CMS will then expand prior authorization nationwide beginning on December 1, 2020. This revised timeframe leaves only three months (instead of the original five) to incorporate lessons learned from the pilot into the nationwide rollout of the program.

In addition, on June 26, the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) and the Pricing, Data Analysis, and Coding Contractor (PDAC) published a joint announcement and a revised Lower Limb Prostheses Local Coverage Article announcing that claims will not be paid for these six prosthetic codes with dates of service on or after January 1, 2021, unless the specific prosthetic component has undergone PDAC code verification and approval to bill a specific L- Code has been published on the appropriate Product Classification List.

Some stakeholders in the orthotic and prosthetic industry have requested that CMS postpone the implementation of prior authorization for the six billing codes until January 1, 2021, which would coincide with the new coding verification requirement issued by the PDAC. These stakeholders have argued that further delay in this new prior authorization is justified because physicians will need to be education on the prior authorization process and will have to cooperate with prosthetists, therapists, and their patients before a patient can receive care that involves components described by any of these billing codes. However, as of this publication, CMS has not announced any intention to further delay the program.

Concerns about prior authorization during a pandemic are obvious. Physicians fighting COVID-19 on the front lines should not be required to be educated about new documentation requirements for Medicare beneficiaries with limb loss to gain access to appropriate prosthetic care. The risk is that providers will seek to avoid delays in obtaining physician documentation by shifting practice patterns away from the six lower limb codes, sending a false signal to CMS that these prosthetic components are not necessary for optimal prosthetic outcomes. Unless and until CMS revises the forthcoming prior authorization requirements, physiatrists should be aware that they will come into effect in the states listed above beginning September 1, with the national rollout following on December 1. For interested practitioners, the DME MAC for Jurisdiction D, Noridian Healthcare Solutions, will be holding a provider outreach and education webinar on the new requirements at noon CT on September 10, 2020. The webinar will include discussion of prior authorization request basics, documentation requirements, and comprehensive error rate testing (CERT). For more information and to register for the webinar, click here.